DART nanoparticle therapy: new treatment for triple-negative breast cancer

Written by Rhiannon Finnie (Future Science Group)

Image showing breast cancer blue treated with DART nanoparticle

Researchers from University of Maryland School of Medicine (UMSOM; MD, USA) have developed a novel DART nanoparticle therapy for aggressive breast cancer that could be superior to the existing drug on the market.  Researchers from the UMSOM have developed a novel nanoparticle drug formulation that targets a specific receptor on triple-negative breast cancer cells. This treatment is reportedly more effective than the standard US FDA approved nanoparticle therapy currently available. In their recent article published in Science Advances and co-authored by others from the Translational Genomics Research Institute (AZ, USA) and Mayo Clinic Arizona (USA), the UMSOM team described their...

To view this content, please register now for access

It's completely free